Updated just now · Live
Stock analysis, price data, and AI-powered insights for Edwards Lifesciences (EW).
Edwards Lifesciences operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for EW.
How to read insider trading filings
Johnson & Johnson
UnitedHealth Group Incorporated
AbbVie Inc.
Merck & Co., Inc.
Eli Lilly and Company
Thermo Fisher Scientific Inc.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). EW Stock Intelligence Report. [stoxpulse.com/stocks/ew]
Disclaimer: The information on this page about Edwards Lifesciences (EW) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Edwards Lifesciences.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No earnings data available.
How The Edwards Lifesciences (EW) Investment Story...
15h ago
Artisan Global Opportunities Fund Q1 2026 Portfoli...
1d ago
StoxPulse AI results for EW: Pulse Score 52.5/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$46.83B
P/E Ratio
—
EPS
$0.50
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sector
Healthcare
Industry
Health Care Equipment
How The Edwards Lifesciences (EW) Investment Story Is Shifting As Views On Growth Diverge
Artisan Global Opportunities Fund Q1 2026 Portfolio Activity
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
Medtronic: Expectations Are Low And That's The Opportunity
Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $110
Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts
EW's Q1 Earnings Beat, Revenues Match, '26 View Up, Stock Climbs
Edwards Lifesciences raises FY26 guidance following strong Q1